Welcome to our dedicated page for BlackRock Enhanced Global Dividend Trust news (Ticker: BOE), a resource for investors and traders seeking the latest updates and insights on BlackRock Enhanced Global Dividend Trust stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BlackRock Enhanced Global Dividend Trust's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BlackRock Enhanced Global Dividend Trust's position in the market.
BlackRock announced final results for tender offers of three closed-end funds. The offers, which expired on November 19, 2024, were oversubscribed for each fund. Each fund will purchase shares from tendering shareholders on a pro rata basis. For BlackRock Science and Technology Term Trust (BSTZ), 19,714,994 shares were tendered, with 1,854,222 to be purchased at $22.3440 per share, representing a pro-ration factor of 0.09414755. Similar results were reported for BCX and BOE funds. Payments are expected within five business days after expiration.
BlackRock announced the expiration and preliminary results of tender offers for three closed-end funds: BSTZ, BCX, and BOE. Each fund offered to repurchase up to 2.5% of its outstanding common shares. The tender offers were significantly oversubscribed, with BCX receiving 20,587,371 shares tendered against 2,056,355 shares offered for repurchase. Due to oversubscription, share purchases will be prorated. The purchase price will be 98% of each fund's NAV as of November 20, 2024.
BlackRock closed-end funds announced final results of their tender offers for up to 2.5% of outstanding common shares. The offers, which expired on August 20, 2024, were oversubscribed for each fund. As a result, shares will be purchased from all tendering shareholders on a pro rata basis. The BlackRock Science and Technology Term Trust (BSTZ) had 23,251,771 shares tendered, with 1,901,766 to be purchased at $21.4522 per share. The pro-ration factor for BSTZ is 0.08188543. Two other BlackRock funds, BCX and BOE, also reported their tender offer results. Payments for accepted shares are expected within five business days after the expiration date.
BlackRock closed-end funds BSTZ, BCX, and BOE announced the expiration and preliminary results of their tender offers for up to 2.5% of outstanding common shares. The offers, which began on July 19, 2024, and ended on August 20, 2024, were significantly oversubscribed. BSTZ offered 1,901,766 shares but received tenders for 23,251,771 shares. BCX and BOE also saw high demand, with tenders exceeding the offered amounts by over 10 times. Due to oversubscription, share purchases will be prorated. The purchase price will be 98% of each fund's NAV as of August 21, 2024. Final results, including pro-ration factors, are expected to be announced around August 21, 2024.
FAQ
What is the current stock price of BlackRock Enhanced Global Dividend Trust (BOE)?
What is the market cap of BlackRock Enhanced Global Dividend Trust (BOE)?
